Decision Aid to Enhance CHD Risk Factor Modification

加强冠心病危险因素修正的决策援助

• 批准号: 6906667
• 负责人: STACEY L SHERIDAN
• 金额: $ 15.34万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-08-01 至 2010-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6906667
• 关键词: Internet; atherosclerosis; behavioral /social science research tag; behavioral medicine; cardiovascular disorder education; cardiovascular disorder prevention; cardiovascular disorder risk; clinical research; computer assisted instruction; coronary disorder; counseling; decision making; education evaluation /planning; educational resource design /development; focus groups; health behavior; human subject; literature survey; patient care personnel relations; patient oriented research; therapy compliance

DESCRIPTION (provided by applicant): Candidate: Stacey L. Sheridan, MD, MPH, is an Assistant Professor of Medicine at the University of North Carolina. She is board certified in prevention, has training in primary care research, and has developed a knowledge base in risk communication and shared decision-making. She has a special interest in coronary heart disease (CHD) prevention. Career Goals: To become a productive independent investigator who can apply rigorous research methods to study and improve patient-provider decision-making about CHD and patient adherence to CHD risk-reducing medications. Career Development Plans: Dr. Sheridan proposes tutorials, mentored research, and professional development activities to help her develop a clinical research focus in CHD prevention, necessary methodological skills, and skills to excel as an independent investigator. Research Study Aims: (1) To collect formative data from appropriately selected patients (at risk, but without diagnosed CHD or diabetes) to understand patient comprehension of global CHD risk, how patients use CHD risk in decision making, and what factors influence patients to adhere to CHD prevention strategies, (2) to develop and/or refine the components of an intervention to improve decision-making and adherence about CHD risk reducing medications (including a web-based decision aid, a web-based coaching tool, a provider education session, and tailored adherence reminders), (3) to pre-test each component of the intervention using cognitive and usability testing methods, and (4) to perform a feasibility study of the intervention (n=200). Significance: This study is responsive to new guidelines that recommend decision-making based on global CHD risk and targets patients' educational and adherence needs in an evidence and theory-based format. This study will provide preliminary data for a subsequent R-01 application to study whether a robust CHD intervention can be used to improve decision-making and adherence in a multi-site randomized trial. Environment: The general medicine ambulatory care clinic at the University of North Carolina. This clinic has a patient-oriented research lab that is conducting similar studies. Mentorship and Clinical Advice: A team of productive and successful researchers will guide Dr. Sheridan in her research and career development. This team has a strong foundation in clinical epidemiology and special expertise in cardiovascular disease prevention (Drs. Simpson, Heiss, and Pignone), behavioral theory and adherence support (Dr. Rimer), preventive service utilization (Dr. Harris), and developing and testing behavioral interventions in high-risk populations (Dr. Keyserling) (End of abstract).

描述（由申请人提供）： 候选人：MPH医学博士Stacey L. Sheridan是北卡罗来纳大学医学助理教授。她获得了预防董事会认证，在初级保健研究方面接受了培训，并在风险交流和共同决策方面建立了知识基础。她对预防冠心病（CHD）特别感兴趣。职业目标：成为一名富有成效的独立研究者，他可以应用严格的研究方法来研究和改善有关冠心病和患者遵守质联神降低风险药物的决策。职业发展计划：Sheridan博士提出了教程，指导研究和专业发展活动，以帮助她在预防冠心病，必要的方法学技能和技能方面培养临床研究重点，以表现为独立研究者。 Research Study Aims: (1) To collect formative data from appropriately selected patients (at risk, but without diagnosed CHD or diabetes) to understand patient comprehension of global CHD risk, how patients use CHD risk in decision making, and what factors influence patients to adhere to CHD prevention strategies, (2) to develop and/or refine the components of an intervention to improve decision-making and adherence about CHD risk reducing medications (including a web-based decision aid, a基于Web的教练工具，提供者教育会议以及量身定制的依从性提醒），（3）使用认知和可用性测试方法预测试干预的每个组成部分，以及（4）对干预措施进行可行性研究（n = 200）。意义：这项研究响应新准则，该指南基于全球冠心病风险，以证据和基于理论的格式针对患者的教育和依从性需求。这项研究将为随后的R-01应用提供初步数据，以研究是否可以在多站点随机试验中使用强大的CHD干预来改善决策和依从性。环境：北卡罗来纳大学的通用医学门诊护理诊所。该诊所有一个以患者为导向的研究实验室，正在进行类似的研究。指导和临床建议：一支富有成效和成功的研究人员团队将指导Sheridan博士的研究和职业发展。该团队在临床流行病学和心血管疾病预防（辛普森博士，Heiss和Pignone博士），行为理论和依从性支持（Rimer博士），预防服务利用（Harris博士）以及开发和测试高风险人群中的行为干预（Keyserplate博士）（摘要）（摘要）。